The Food and Drug Administration has granted Teva Pharmaceuticals USA tentative approval to sell a generic version of Pfizer Inc.'s cholesterol blockbuster, Lipitor.
The agency says Teva's research data shows its pill is safe and effective.
The FDA cannot grant final approval until May 31. India's Ranbaxy Laboratories has the exclusive right to sell generic Lipitor, or atorvastatin, for 180 days after Lipitor's U.S. patent expired on Wednesday, because it was the first company to successfully challenge Lipitor's patent.
Ranbaxy began shipping its version after getting FDA approval late Wednesday. Watson Pharmaceuticals Inc. is selling an authorized generic under a partnership with Pfizer.
Teva USA is part of Israel's Teva Pharmaceutical Industries Ltd.
2016 Election Primary Results
Toxic Words | Human Events
'Priceless': San Antonio Spurs coach reacts after finding out winners of #NHPrimary [video, gif]
End of the Line for These Three Republicans | RedState
Can You Bring Criminal Charges Against Someone Who Owes You Money?
Open thread: The battle for New Hampshire’s silver medal; Update: Fox calls Trump, Sanders winners; Update: Fox, ABC, NBC call silver for Kasich
After Youtube Terminated His Account Twice, Hickok45 Found A New Home